Objectives: The aim of this study was to determine the prevalence of antibiotic-resistant bacteria, especially extended-spectrum beta-lactamase (ESBL) producing Escherichia coli, in samples from healthy adults, foods, food animals, and the environment in selected areas of Thailand. Methods: Samples were collected from stool specimens from adult food factory and food animal farm workers, fresh and cooked foods sold at markets, rectal swabs of healthy pigs and chickens, fresh pork meat from slaughterhouses, water samples from canals as well as fish and shrimp farm ponds, and stagnant water sources on pig farms. Antibiotic susceptibility was determined using the disk diffusion or agar dilution methods. Extended-spectrum beta-lactamase production was assayed using a double disk diffusion method. Results: Among 544 healthy adult food factory workers, 75.5% were positive for ESBL producing E. coli, while 77.3% of E. coli isolated from 30 healthy animal farm workers were positive. Amongst healthy food animals, ESBL producing status among E. coli isolates were more commonly detected in pigs (76.7%) than broilers (40%). Extended-spectrum beta-lactamase producing E. coli seemed to be more prevalent in fresh meat samples than in fresh vegetables, in fresh foods than in cooked foods, and in water samples collected from the animal farms than those from canals and fish and shrimp ponds. Conclusions: Extended-spectrum beta-lactamase producing E. coli isolates are prevalent amongst healthy individuals, foods along the food production chain from farms to consumers, and in the environment in selected areas in Thailand.
To investigate the nasal carriage of antibiotic-resistant pneumococci by children, anterior nasal swabs were done for 4963 children <5 years old in 11 countries in Asia and the Middle East. In total, 1105 pneumococci isolates (carriage rate, 22.3%) were collected, 35.8% of which were found to be nonsusceptible to penicillin. Prevalence of penicillin nonsusceptibility was highest in Taiwan (91.3%), followed by Korea (85.8%), Sri Lanka (76.5%), and Vietnam (70.4%). Penicillin resistance was related to residence in urban areas, enrollment in day care, and a history of otitis media. The most common serogroups were 6 (21.5%), 23 (16.5%), and 19 (15.7%). The most common clone, as assessed by pulsed-field gel electrophoresis, was identical to the Spanish 23F clone and to strains of invasive isolates from adult patients. Data in this study documented the high rate of penicillin or multidrug resistance among isolates of pneumococci carried nasally in children in Asia and the Middle East and showed that this is due to the spread of a few predominant clones in the region.
Abstract. A prospective study in Thailand identified 106 patients with culture-proven leptospirosis. The accuracy of the microscopic agglutination test (MAT) in predicting the infecting serovar was evaluated in 78/106 (74%) patients with a diagnostic titer. MAT correctly determined the infecting serovar in 26 cases (33%), indicating that this assay is a poor predictor of infecting serovar in our setting.Leptospirosis is an acute febrile illness caused by pathogenic members of the genus Leptospira . This disease has a worldwide distribution but is most common in tropical regions, including Thailand. [1][2][3][4][5] In a prospective observational study of undifferentiated fever in 845 patients in rural Thailand, leptospirosis was reported to be responsible for 36.9% of cases.4 Leptospira isolation is the gold standard for confirmation of leptospirosis in humans. This provides definitive identification of the infecting serovar and is an important technique for the study of outbreaks and global epidemiology. It has a number of significant drawbacks, however, including low diagnostic sensitivity, prolonged culture period, and the associated expertise necessary for identification of the infecting serovar together with related costs.The microscopic agglutination test (MAT) is commonly used to reach a serologic diagnosis of leptospirosis and is performed by detecting agglutinating antibodies by mixing patient serum with a panel of Leptospira serovars that are considered to be representative of the endemic strains for a given region. 3A positive diagnostic result for the MAT is a 4-fold change in titer or a single pre-defined titer. MAT has also been used to provide an indication of the presumptive serovars causing leptospirosis in a given region. The ability of MAT to accurately determine the prevalent serovars was called into question by a retrospective study conducted in Barbados where disease in 151 individuals was caused by four serovars ( L. kirschneri serovar Bim, L. interrogans serovar Copenhageni, L. borgpetersenii serovar Arborea, and L. noguchii serovar Bajan); serologic analysis was found to have a low degree of accuracy for determining the infecting serovar in this setting. 6 The epidemiology of infecting isolates in Thailand differs markedly, with a recent study showing that the majority of human disease was caused by L. interrogans serovar Autumnalis. 7 The aim of this study was to determine whether MAT provides an accurate guide to the infecting serovars of Leptospira in Thailand.A prospective study was conducted in hospitals situated in six provinces in northeast Thailand (Udon Thani, Burirum, Loei, Nakhon Ratchasima, Maha Sarakham, and Yasothon) between October 2000 and December 2006 to identify patients with culture proven leptospirosis. The study protocol was approved by the Ethical Committee of the Ministry of Public Health, Royal Government of Thailand. Admitting physicians were asked to recruit patients of all ages who they suspected on clinical grounds to have leptospirosis. Clinical features cons...
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.